Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course.

Conclusion: Monocytopenia, especially anemia, was the most common type of cytopenia. The cytopenia was predominantly grade 2, developed in majority of the patients within 6 months after imatinib initiation, and had resolved by 24-36 months after imatinib initiation. PMID: 32454829 [PubMed]
Source: Advances in Hematology - Category: Hematology Tags: Adv Hematol Source Type: research